2025-02-21 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**0. Key Figures & Initial Analysis:**

ISRG, Intuitive Surgical Inc., is a leading developer and manufacturer of robotic surgery systems.  The provided data shows significantly higher returns compared to the S&P 500 (VOO).


**1. Performance Comparison & Divergence:**

* **ISRG Cumulative Return:** 331.64%
* **VOO (S&P 500) Cumulative Return:** 121.84%
* **Return Divergence:** 209.8% (relative divergence of 94%, indicating ISRG's performance is significantly higher than the S&P 500 based on historical data).

The historical data indicates that ISRG has significantly outperformed the S&P 500 over the period examined.  The high relative divergence suggests this outperformance is in the upper percentiles of historical comparisons.


**Alpha & Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 77.0% | 7.3% | 49.0% | -0.0 | 43.4 |
| 2016-2018  | 89.0% | 8.9% | 71.0% | 0.0 | 56.9 |
| 2017-2019  | 93.0% | 9.8% | 63.0% | 0.5 | 70.3 |
| 2018-2020  | 71.0% | 9.8% | 43.0% | 0.2 | 97.3 |
| 2019-2021  | 113.0% | 9.8% | 42.0% | 0.2 | 128.2 |
| 2020-2022  | 21.0% | 20.6% | 12.0% | 0.2 | 94.6 |
| 2021-2023  | 19.0% | 20.6% | -4.0% | 1.0 | 120.3 |
| 2022-2024  | 128.0% | 20.4% | 95.0% | 1.0 | 186.2 |
| 2023-2025  | 226.0% | 9.9% | 163.0% | 0.8 | 212.4 |

The high and fluctuating CAGR (Compound Annual Growth Rate) shows significant growth potential but also inherent volatility. The Alpha values suggest periods of outperformance against the benchmark, however the Beta values suggest a high level of correlation to the market, especially in later periods.  The increasing market cap reflects the company's growth.

**2. Recent Price Movement:**

* **Closing Price:** $595.55
* **5-Day Moving Average:** $592.78
* **20-Day Moving Average:** $587.84
* **60-Day Moving Average:** $556.35

The price is slightly above its short-term moving averages, suggesting a modestly positive short-term trend.  The price is significantly above the 60-day average, indicating a stronger upward trend in the medium term.


**3. Technical Indicators & Expected Return:**

* **RSI:** 65.87 (Slightly above neutral, suggesting neither overbought nor oversold conditions)
* **PPO:** -0.11 (Negative, indicating bearish momentum, although close to neutral)
* **20-Day Relative Divergence Change:** +2.5 (Suggests a short-term upward trend)
* **Expected Return (2+ years):** 19.7% (This is a significant outperformance compared to the S&P 500 and suggests potential for substantial long-term growth).

The mixed signals from RSI and PPO suggest cautious optimism.  The positive relative divergence change supports the short-term upward momentum.  The high expected return is a major positive.

**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2024-10-18 | 1.59 | $2.04 B      |
| 2024-07-19 | 1.48 | $2.01 B      |
| 2024-04-19 | 1.54 | $1.89 B      |
| 2023-10-20 | 1.18 | $1.74 B      |
| 2024-10-18 | 1.18 | $1.74 B      | *(There seems to be a duplicate entry here, please verify the data)*


Revenue shows consistent growth, while EPS fluctuates but generally trends upward.  Further analysis is needed to determine the sustainability of this growth.

**5. Financial Information:**

The absence of "Total Revenue" and "Gross Profit" data prevents a comprehensive financial analysis.  This is a critical data gap and needs to be addressed.

**6. Overall Analysis:**

ISRG has demonstrated strong historical performance, significantly outperforming the S&P 500. Recent price action suggests a modestly positive short-term trend and a stronger medium-term upward trend.  While some technical indicators give mixed signals, the high expected return and generally increasing revenue are positive. However, the lack of crucial financial data (Total Revenue, Gross Profit) significantly limits the depth of this analysis.   Further investigation into the missing financial data and a deeper dive into the company's competitive landscape and growth drivers are recommended before making any investment decisions.  The seemingly duplicate entry in the earnings report also needs clarification.
